Exosomes Derived from Hypoxic Glioma Cells Reduce the Sensitivity of Glioma Cells to Temozolomide Through Carrying miR-106a-5p

References

• Chen X, Niu W, Fan X, et al. Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells. Neuro Oncol. 2022. doi:10.1093/neuonc/noac157
   Web of Science ®Google Scholar
• Pan E, Mitchell SB, Tsai JS. A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients. J Neurooncol. 2008;88(3):353–357. doi:10.1007/s11060-008-9576-7
   PubMed Web of Science ®Google Scholar
• McMahon DJ, Gleeson JP, O’Reilly S, Bambury RM. Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches. Med Oncol. 2022;39(9):129. doi:10.1007/s12032-022-01708-w
   PubMed Web of Science ®Google Scholar
• Li B, Wang J, Liu F, et al. A novel pseudogene methylation signature to predict temozolomide outcome in Non-G-CIMP glioblastomas. J Oncol. 2022;2022:6345160. doi:10.1155/2022/6345160
   PubMed Web of Science ®Google Scholar
• Chen M, Huang B, Zhu L, et al. DNA damage response evaluation provides novel insights for personalized immunotherapy in glioma. Front Immunol. 2022;13:875648. doi:10.3389/fimmu.2022.875648
   PubMed Web of Science ®Google Scholar
• Wang YH, Gu J, Yu JH, et al. Diffuse midline glioma with H3-K27M mutation: a rare case with GFAP-positive anucleate whorled patterns. Medicine. 2022;101(24):e29448. doi:10.1097/MD.0000000000029448
   PubMed Web of Science ®Google Scholar
• Zhou J, Xu N, Liu B, et al. lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2-mediated PI3K/AKT pathway in glioma. Cancer Sci. 2022;113:2681–2692. doi:10.1111/cas.15387
   PubMed Web of Science ®Google Scholar
• Zhou Y, Chen L, Ding D, et al. Cyanidin-3-O-glucoside inhibits the beta-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells. Sci Rep. 2022;12(1):7773. doi:10.1038/s41598-022-11757-w
   PubMed Web of Science ®Google Scholar
• Zichittella C, Barreca MM, Cordaro A, et al. Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells. BMC Cancer. 2022;22(1):567. doi:10.1186/s12885-022-09666-2
   PubMed Web of Science ®Google Scholar
• Jiang S, Li X, Zhang F, et al. Manganese dioxide-based nanocarrier delivers paclitaxel to enhance chemotherapy against orthotopic glioma through hypoxia relief. Small Methods. 2022;6:e2101531. doi:10.1002/smtd.202101531
   PubMed Web of Science ®Google Scholar
• Assidicky R, Tokat UM, Tarman IO, et al. Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer. Breast Cancer Res Treat. 2022;193(2):331–348. doi:10.1007/s10549-022-06569-5
   PubMed Web of Science ®Google Scholar
• Qin Y, Liu HJ, Li M, et al. Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1α signaling pathway. EBioMedicine. 2018;38:25–36. doi:10.1016/j.ebiom.2018.10.069
   PubMed Web of Science ®Google Scholar
• Cheng S, Huang Y, Lou C, et al. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation. Cancer Biol Ther. 2019;20(3):328–337. doi:10.1080/15384047.2018.1529101
   PubMed Web of Science ®Google Scholar
• Li H, Chen L, Li JJ, et al. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. J Hematol Oncol. 2018;11(1):70. doi:10.1186/s13045-018-0618-0
   PubMed Web of Science ®Google Scholar
• Chen HA, Li CC, Lin YJ, et al. Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cells. Aging. 2021;13(8):12046–12057. doi:10.18632/aging.202908
   PubMedGoogle Scholar
• Li P, Lu X, Wang Y, et al. MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells. J Biomed Res. 2010;24(6):436–443. doi:10.1016/S1674-8301(10)60058-9
   PubMedGoogle Scholar
• Chen W, Wu M, Cui ST, et al. CircRNA Circ-ITCH inhibits the proliferation and invasion of glioma cells through targeting the miR-106a-5p/SASH1 axis. Cell Transplant. 2021;30:963689720983785. doi:10.1177/0963689720983785
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Wang H, Wu D. MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2. Int J Clin Exp Pathol. 2018;11(12):5622–5634.
   PubMed Web of Science ®Google Scholar
• Alharbi M, Lai A, Sharma S, et al. Extracellular vesicle transmission of chemoresistance to ovarian cancer cells is associated with hypoxia-induced expression of glycolytic pathway proteins, and prediction of epithelial ovarian cancer disease recurrence. Cancers. 2021;13:14. doi:10.3390/cancers13143388
   Web of Science ®Google Scholar
• Sayyed AA, Gondaliya P, Mali M, et al. MiR-155 inhibitor-laden exosomes reverse resistance to cisplatin in a 3D tumor spheroid and xenograft model of oral cancer. Mol Pharm. 2021;18(8):3010–3025. doi:10.1021/acs.molpharmaceut.1c00213
   PubMed Web of Science ®Google Scholar
• Ipas H, Guttin A, Issartel JP. Exosomal MicroRNAs in Tumoral U87 MG versus normal astrocyte cells. Microrna. 2015;4(2):131–145. doi:10.2174/2211536604666150820115707
   PubMedGoogle Scholar
• Zhuang L, Zhang B, Liu X, et al. Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1. Cell Biol Int. 2021;45(10):2140–2149. doi:10.1002/cbin.11671
   PubMed Web of Science ®Google Scholar
• Liu Y, Tan J, Ou S, Chen J, Chen L. Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the VHL/HIF axis. J Physiol Biochem. 2019;75(3):391–401. doi:10.1007/s13105-019-00692-6
   PubMed Web of Science ®Google Scholar
• Zhang S, Guan N, Mao X, et al. Exosomal circRNA_104948 enhances the progression of glioma by regulating miR-29b-3p and DNMT3B/MTSS1 Signaling. J Environ Pathol Toxicol Oncol. 2022;41(2):47–59. doi:10.1615/JEnvironPatholToxicolOncol.2021039775
   PubMed Web of Science ®Google Scholar
• Chen M, Cheng Y, Yuan Z, et al. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24. Cancer Biother Radiopharm. 2020;35(2):101–108. doi:10.1089/cbr.2019.3054
   PubMed Web of Science ®Google Scholar
• Vengoji R, Macha MA, Nimmakayala RK, et al. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. J Exp Clin Cancer Res. 2019;38(1):266. doi:10.1186/s13046-019-1264-2
   PubMed Web of Science ®Google Scholar
• Qian D, Xie Y, Huang M, Gu J. Tumor-derived exosomes in hypoxic microenvironment: release mechanism, biological function and clinical application. J Cancer. 2022;13(5):1685–1694. doi:10.7150/jca.69278
   PubMed Web of Science ®Google Scholar
• Onishi H, Nakamura K, Yanai K, et al. Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review). Oncol Rep. 2022;47(5). doi:10.3892/or.2022.8304
   PubMed Web of Science ®Google Scholar
• Zeng Z, Zhao Y, Chen Q, et al. Hypoxic exosomal HIF-1alpha-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Oncogene. 2021;40(36):5505–5517. doi:10.1038/s41388-021-01960-w
   PubMed Web of Science ®Google Scholar
• Dong C, Liu X, Wang H, et al. Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin. Onco Targets Ther. 2019;12:1947–1956. doi:10.2147/OTT.S186922
   PubMed Web of Science ®Google Scholar
• Zhu X, Shen H, Yin X, et al. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype. J Exp Clin Cancer Res. 2019;38(1):81. doi:10.1186/s13046-019-1095-1
   PubMed Web of Science ®Google Scholar
• Qian M, Chen Z, Guo X, et al. Exosomes derived from hypoxic glioma deliver miR-1246 and miR-10b-5p to normoxic glioma cells to promote migration and invasion. Lab Invest. 2021;101(5):612–624. doi:10.1038/s41374-020-00522-0
   PubMed Web of Science ®Google Scholar
• Yue X, Lan F, Xia T. Hypoxic glioma cell-secreted exosomal miR-301a Activates Wnt/β-catenin signaling and promotes radiation resistance by targeting TCEAL7. Mol Ther. 2019;27(11):1939–1949. doi:10.1016/j.ymthe.2019.07.011
   PubMed Web of Science ®Google Scholar
• Jeon H, Seo SM, Kim TW, et al. Circulating Exosomal miR-1290 for diagnosis of epithelial ovarian cancer. Curr Issues Mol Biol. 2022;44(1):288–300. doi:10.3390/cimb44010021
   PubMed Web of Science ®Google Scholar
• Wang P, Li GY, Zhou L, et al. Exosomes from M2 macrophages promoted glycolysis in FaDu cells by inhibiting PDLIM2 expression to stabilize PFKL. Neoplasma. 2022. doi:10.4149/neo_2022_220426N455
   Web of Science ®Google Scholar
• Guo W, Yao X, Lan S, et al. Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptisis in hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis. Chin Med. 2022;17(1):76. doi:10.1186/s13020-022-00628-1
   PubMed Web of Science ®Google Scholar
• Wu W, Lu P, Huang Y, et al. Emodin regulates the autophagy via the miR-371a-5p/PTEN axis to inhibit hepatic malignancy. Biochem Biophys Res Commun. 2022;619:1–8. doi:10.1016/j.bbrc.2022.06.006
   PubMed Web of Science ®Google Scholar
• Conciatori F, Salvati E, Ciuffreda L, et al. Fibroblast-Induced Paradoxical PI3K pathway activation in PTEN-competent colorectal cancer: implications for therapeutic PI3K/mTOR Inhibition. Front Oncol. 2022;12:862806. doi:10.3389/fonc.2022.862806
   PubMed Web of Science ®Google Scholar
• Sahoo SS, Ramanand SG, Gao Y, et al. FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity. J Clin Invest. 2022;132(12). doi:10.1172/JCI157574
   PubMed Web of Science ®Google Scholar
• Zhu M, Zhang N, He S, Lu X. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7. Cell Cycle. 2020;19(10):1200–1221. doi:10.1080/15384101.2020.1749467
   PubMed Web of Science ®Google Scholar
• Troncone E, Marafini I, Stolfi C, Monteleone G. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer. Int J Mol Sci. 2021;22(8):3922. doi:10.3390/ijms22083922
   PubMed Web of Science ®Google Scholar
• Tang J, Li X, Cheng T, Wu J. miR-21-5p/SMAD7 axis promotes the progress of lung cancer. Thorac Cancer. 2021;12(17):2307–2313. doi:10.1111/1759-7714.14060
   PubMed Web of Science ®Google Scholar